BCA2 has been found to be overexpressed in breast cancer, and its involvement has been observed in various physiological and pathological processes, including tumor formation, membrane receptor trafficking, DNA damage response and repair, innate immune signaling, and autophagosome formation18-22. Here, RNF115 is linked to breast cancer.